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Introduction
Release of large quantities of 131I in the aftermath of
the Chernobyl nuclear power plant accident in April
1986 led to an unprecedented exposure of thyroid tis-
sues to radioiodine in the inhabitants of the nearby
regions of the Ukraine, Belarus and Russia. Normally,
iodine in the diet is absorbed in the intestine as inor-
ganic iodide, concentrated by the thyroid gland and
incorporated in precursors of thyroid hormones [1].
Within a few years following the accident, the inci-
dence of childhood papillary thyroid carcinomas
(chPTC; defined as PTC in patients under the age of 16
at the time of surgery) in regions near the accident site
had increased dramatically. For example, in the most
contaminated Gomel region, chPTC rates before the
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Abstract: Structural chromosome aberrations are known hallmarks of many solid tumors.  In the papillary form of thyroid
cancer (PTC), for example, activation of the receptor tyrosine kinase (RTK) genes, RET and neurotrophic tyrosine kinase
receptor type I (NTRK1) by intra- and interchromosomal rearrangements has been suggested as a cause of the disease. How-
ever, many phenotypically similar tumors do not carry an activated RET or NTRK-1 gene or express abnormal ret or NTRK-
1 transcripts. Thus, we hypothesize that other cellular RTK-type genes are aberrantly expressed in these tumors. Using flu-
orescence in situ hybridization-based methods, we are studying karyotype changes in a relatively rare subgroup of PTCs,
i.e., tumors that arose in children following the 1986 nuclear accident in Chernobyl, Ukraine. Here, we report our technical
developments and progress in deciphering complex chromosome aberrations in case S48TK, an aggressively growing PTC
cell line, which shows an unusual high number of unbalanced translocations. 
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accident were about 0.5 cases/million children/year [2-
3], but then rose to a tumor burden of approximately
100 cases/million children/year in 1994 [4-5].
Although rare in children, PTC is the most common
cancer of the thyroid gland in adults [6-7]. Rearrange-
ments of chromosomes 1 and 10 are common cytoge-
netic changes in PTC [8-10], while loss of heterozy-
gosity (LOH) for loci on chromosome 3 had initially
been reported only in follicular TC [11-12]. A correla-
tion of alterations involving the chromosomal region
10q11 to thyroid tumorigenesis was supported by the
frequent finding of a truncated RET proto-oncogene,
which localizes to the same chromosomal band [13].
Reported aberrations range from unconfirmed small
interstitial deletions to larger intra- and interchromoso-
mal rearrangements and chromosome loss. While stud-
ies reported chromosomal changes in cases of adult-
hood PTC, there is only limited information regarding
the cytogenetic alterations in chPTC [14-16].
Currently, clinical and biological characteristics
such as patient age, tumor size, extent, distant metas-
tases, aneuploidy and cyclase activity are monitored to
predict tumor behavior, but a molecular genetic mark-
er is needed to preoperatively distinguish between less
aggressive and more aggressive well-differentiated
thyroid cancers [17]. The RET/PTC oncogene, an acti-
vated form of the RET proto-oncogene, which maps to
chromosome 10q11.2 and encodes a transmembrane
RTK gene, could serve as a molecular marker differ-
entiating low from high risk papillary thyroid cancer
[18,19].  Major types of RET rearrangements (termed
RET/PTC1, RET/PTC2, RET/PTC3) show the tk
domain of RET fused in frame with the 5' part of a
constitutively expressed gene and thus producing a
chimeric mRNA which is translated into a hybrid pro-
tein with kinase activity [20]. RET/PTC1 and
RET/PTC3 are paracentric inversions on the long arm
of chromosome 10, while RET/PTC2 is caused by a
reciprocal translocation t(10;17) [10,11,18,21,22].
Additional variants of RET rearrangements have been
described in individual cases, but in the three major
types of rearrangements, the breakage within the RET
gene was found in intron 11 upstream of the tk domain
[22].
The human gene for NTRK1 encodes a signal
transducing transmembrane receptor that is stimulated
by nerve growth factor. This gene maps to chromo-
some 1 band q21-22 [23], and its expression in normal
tissue is limited to neural-crest derived sensory neu-
rons. Aberrant forms of NTRK1 created by in-frame
fusion of its tk domain with 5'-sequences of the human
non-muscular tropomyosin gene (TPM3) have been
found in colon and thyroid carcinomas [16,24-26].
The key elements of thyroid tumorigenesis are still
unknown. Recent reports suggesting that the aberrant
expression of genes involved in apoptosis or cell pro-
liferation may play an important role in the malignant
transformation of benign thyroid neoplasms or the pro-
gression of well differentiated thyroid cancer to the
much more aggressive anaplastic carcinomas still
await confirmation in larger study cohorts [27,28].
On the other hand, activation and aberrant expres-
sion of RTK genes other than RET or NTRK1 could
explain findings where many of the cases or individual
cells in tumor cell cultures showed neither evidence of
chromosomal rearrangements nor expression of the ret
or NTRK1 oncogene [26,29,30]. 
There is growing evidence that small, 'submicro-
scopic' lesions lead to disease phenotypes and tumors
[31,32]. Present techniques for karyotype analyses are
based on Giemsa (G)-banding, whole chromosome
painting (WCP) or Spectral Karyotyping (SKY).
These techniques fail to detect deletions or transloca-
tions smaller than ~10 Mbp, i.e., roughly the size of a
chromosome band. However, fluorescence in situ
hybridization (FISH) with gene- or locus-specific
probes is sensitive enough to tag specific DNA
sequences in interphase or metaphase cells. Our
approach combines the high specificity of bacterial
artificial chromosome (BAC)-derived DNA probes
with the sensitive single-cell detection capability of
FISH, thus enabling the rapid and unambiguous detec-
tion of small translocations, duplications and inver-
sions necessary to identify and characterize occult
translocations in chPTC [33].
Materials and methods
Metaphase spreads were made from short-term cultures of lym-
phocytes from an anonymous normal male donor were grown for
72 h in RPMI 1640 (Invitrogen, Carlsbad, CA) 10% fetal bovine
serum, 1% penicillin/streptomycin and 2% phytohaemagglutinin
(PHA, HA-15; Abbott Molecular, Inc, Des Plaines, IL). Cells were
blocked in mitosis by treatment with colcemid (0.12 µg/ml, Invit-
rogen, San Diego, CA) for 30 min. The tumorigenic cell line
S48TK was prepared from a thyroid cancer that arose following
the 1986 nuclear accident in Chernobyl, Ukraine [30]. At the time
of exposure to elevated levels of radiation, the patient was 7 years
old and had reached age 14 at the time of surgery at the Center for
Thyroid Tumors in Minsk, Belarus [34]. The S48TK cells were
kept in culture for several weeks as described [30,34], and blocked
with colcemid (0.4-0.8 µg/ml) 1-2 hrs prior to harvest.  All cells
were pelleted and incubated in 75 mM KCl for 15 min at 37°C. The
cells were then spun down, and approximately 107 cells were fixed
in three changes of Carnoy's fixative (acetic acid:methanol, 1:3
(vol/vol). Finally, the cells were dropped on ethanol-cleaned glass
slides and aged for a minimum of 1 week in ambient air at 20°C,
sealed in plastic bags and stored at -20oC until used.
Fluorescence in situ hybridization. Using information in pub-
licly available databases (http://genome.ucsc.edu/ and
http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi), we selected
BAC clones for the long arm of chromosome 1 from the Roswell
Park Cancer Institute (RPCI) library RP11 (Table 1). For DNA iso-
lation and preparation of DNA probes from individual clones, BAC
DNA was isolated from 10 ml bacterial overnight cultures contain-
ing 12.5 µg/ml chloramphenicol (Sigma, St. Louis, MO) using an
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alkaline lysis and 2-propanol DNA precipitation [23]. Briefly, cell
pellets resuspended in 10 ml of phosphate-buffered saline (PBS)
containing 50 µg/ml lysozyme (Sigma) and lyzed in sodium
hydroxide (0.2 N NaOH, 1% SDS). After neutralization by addi-
tion of 3 M NaOAc, bacterial DNA was pelleted. The supernatant
was transferred to clean tubes, and DNA was precipitated in 2-
propanol, washed once with cold 70% ethanol, and resuspended in
TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Then, the
DNA was extracted once with phenol:chloroform, precipitated
again with 2-propanol, and resuspended in 20-40 µl sterile water.
The DNA concentrations were determined using a TKO100 instru-
ment and Hoechst 33342 fluorometry (Hoefer, San Francisco, CA)
[23]. The BAC-derived DNA (typically 1-2 µl of DNA in a 10 µl
reaction) was labeled via random priming following the instruction
of the kit manufacturer (BioPrime Kit, Invitrogen) [35] incorporat-
ing biotin-14-dCTP (part of the BioPrime kit), digoxigenin-11-
dUTP (dig-11-dUTP, Roche Molecular Biochemicals, Indianapo-
lis, IN), fluorescein-12-dUTP (Roche Molecular Biochemicals),
Cy5-dUTP (Amersham, Arlington Heights, IN) or Cy5.5-dCTP
(Perkin Elmer, Wellesley, MA) [10,34,35].
The clones we used to label specific regions of chromosome 9
were a subset of the Sanger Centre 1Mbp set [34,36]. A total of 150
BAC clones (50 and 100 clones for the short and long arms of
chromosomes, respectively) were grown overnight in 2 ml LB
medium plus chloramphenicol each  96-well in deep-well plates
(Becton Dickinson, San Jose, CA) [34]. The preparation of DNA
probes representing BAC pools was performed in the way
described for single clones with the following modification: 1 ml
from each culture was combined in the desired pool, the cells were
spun down, resuspended in 10 ml PBS containing 50 µg/ml
lysozyme, and DNA was isolated and labeled as described above.
Prior to hybridization of DNA probes to S48TK cells, all probes
were tested on normal male metaphase spreads to ensure sufficient
signal strength, correct cytogenetic map positions and absence of
chimerism.
For FISH, we combined 1 μl of each probe, 1-4 μl of human
COT-1™ DNA (1 mg/ml, Invitrogen), 1 μl of salmon sperm DNA
(10 mg/ml, Invitrogen) and 7 μl of a hybridization master mix
(78.6% formamide (FA)(Invitrogen), 14.3% dextran sulfate in 
1.43 × SSC, pH 7.0 (20×SSC is 3 M sodium chloride, 300 mM tri-
sodium citrate) [35]. If more than three probes were combined, we
precipitated the probes in 2-propanol, and resuspended the pellet in
3  l water prior to addition of COT-1™ DNA and the hybridization
master mix [34]. The mixture was denatured in a waterbath at
76oC for 10 min and incubated for 30 min at 37°C to pre-anneal
blocking DNA with the probes. At this time, the slides were dena-
tured for 4 min at 76oC in 70% formamide/2× SSC, pH 7.0, dehy-
drated in a 70%, 85%, 100% ethanol series for 2 min each step, and
air dried. Ten microliters of the hybridization mixture was pipetted
on to the cells, covered with a 22×22 mm2 coverslip and sealed
with rubber cement. Following overnight hybridization at 37°C
and coverslip removal, the slides were washed twice in 50% FA/2x
SSC at 45°C for 10 min each followed by two washes in 2x SSC
at 21°C. Cells were then incubated 5 min in PNM (5% nonfat dry
milk, 1% sodium azide in PN buffer (0.1 M Na phosphate buffer,
pH 8.0, 1% Nonidet-P40 (Sigma))) at 21°C, before bound non-flu-
orescent probes were detected with fluorescein-conjugated avidin
DCS (Vector, Burlingame, CA) or anti-digoxigenin-rhodamine
(Roche) [23,35]. Finally, the slides were mounted in 4 ,6-diamidi-
no-2-phenylindole (DAPI) (0.5 µg/ml; Calbiochem, La Jolla, CA)
in antifade solution [23]. Spectral Karyotyping analysis was per-
formed with commercially available probes (Applied Spectral
Imaging, Inc., Carlsbad, CA) following the manufacturer's instruc-
tions [30,34].
Image acquisition and analysis. Fluorescence microscopy was
performed on a Zeiss Axioskop microscope equipped with a filter
sets for observation of Cy5/Cy5.5, Texas Red/rhodamine. FITC or
DAPI (84000v2 Quad, ChromaTechnology, Brattleboro, VT).
Images were collected using a CCD camera (VHS Vosskuehler,
Osnabrueck, FRG) and processed using Adobe Photoshop® soft-
ware (Adobe Inc., Mountain View, CA).
Results
Karyotype analysis cell line S48TK using G-banding
or SKY had indicated numerous translocations among
several complex translocations [30,34](Fig.1A-D).
Our interest in rearrangements of the long arm of chro-
mosome 1 was initiated by the observation that sever-
al derivative chromosomes carried chromosome 1-
derived material, the proximal long arm of chromo-
some 1 harbors the NTRK1 genes and comparative
genomic hybriddization (CGH) indicated extra copies
of the proximal region  of chromosome1q [34]. A first
hybridization of BAC-derived DNA probes that flank
the NTRK1 locus and cover a region of chromosome 1
from roughly 154 Mbp to 155 Mbp (Table 1) indicat-
ed two copies of a der(1) with a potentially truncated
long arm. On both of these chromosomes, we observed
one red and one green signal per chromatid without
indication of a high level amplification of the region
around 1q22 to which NTRK1 maps [23](Fig.1E). The
FISH signals were in close proximity and partially
overlapping as one would expect from BAC probes
that bind just 1.2 Mbp apart from each other (Table 1).
Interestingly, both copies of the der(1) showed a
reversed order of BAC probes RP11-243J18 (dig.-
labeled, red fluorescent detection) and RP11-110J1
(biotin-labeled, green signals after avidin-FITC detec-
tion) on 1q (Table 1) with the green signal found more
proximal that the red signals indicative for an inver-
sion (Fig. 1E).
This result prompted an investigation whether the
region of chromosome 1 between 144 Mbp and 154
Mbp, i.a., around TPM3, a reported fusion partner of
NTRK1 in PTC, was also rearranged or not. We com-
bined the same dig-labeled probe RP11-243J18 with a
biotinylated probe prepared from BAC RP11-315I20,
a clone which on normal chromosomes 1 binds about
10 Mbp proximal of RP11-243J18. Hybridization of
this probe combination to S48TK metaphase spreads
showed signals on two marker chromosomes  labeled
M1 and M2 (Fig.1F). The marker M1 showed overlap-
ping red and green FISH signals, while marker M2
chromosome showed at least three green and two red
hybridization domains per chromatid (Fig.1F, top).
The inserts in Figure 1F show enlarged FISH and
DAPI pictures of the marker chromosomes, which
may explain the CGH results reported earlier [34]. In
summary, complex chromosomal changes found on
the long arm of chromosome 1 in the chPTC cell line
S48TK warrant a further, high resolution investigation
of rearrangements that might have lead to the malig-
nant transformation of the progenitors of these cells.
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While oncogenic activation of tk genes from chro-
mosome 1 or 10, i.a., NTRK1 or ret, respectively, has
been reported, the literature does not indicated involve-
ment of chromosome 9 in the pathogenesis of PTC.
Cell line S48TK shows several marker chromosomes
that carry chromosome 9-derived material among them
a large der(7)t(7;9;15) (Fig.1G). We were particularly
interested in characterizing a small piece of chromo-
some 9 inserted into a der(8)t(8;15) marker chromo-
some (arrow in Fig. 1G) [34]. To rapidly determine the
origin of this small insert, we decided to apply pools of
BAC clones and combinations of pools, so-called
'superpools'. All BACs were selected from the Sanger
Center 1 Mbp set [36]. In total, we chose 50 clones that
map to the short arm of chromosome 9, and 100 clones
that map to the long arm. As depicted in Fig.2, BAC
clones were arrayed in 96-well microtiter plates so that
the most distal clone on the short arm of chromosome 9
was placed in position A1 and each row contained
between 8 and 11 clones that mapped into an interval of
several megabasepairs [34]. To expedite the characteri-
zation of the small insert, we labeled the five pools that
map to the short arm of chromosome 9 (pools 9-1 to 9-
5) with digoxigenin. Pools that map to the long arm
were combined in pairs and labeled with biotin (Table
2). All probes were then combined in one hybridization
mixture. Hybridization of these chromosome 9 arm
probes (CAP9) onto normal metaphase chromosomes
showed the desired effect of painting the short and long
arms in red and green, respectively (Fig.1H).
Hybridization of the CAP9 probe to S48TK metaphase
spreads revealed 4 different types of chromosomes with
material from chromosome 9, among them the marker
with the small insert (arrow in Fig.1H). Due to its green
fluorescence, the insert was confirmed as being derived
from chromosome 9q. When superpools for chromo-
some 9q were label with five different reporter mole-
cules as shown schematically in Fig.1I and hybridized
to S48TK metaphase spreads, the small insert was iden-
tified by its green fluorescence as being the hybridiza-
tion target of pools 9-10 + 9-11 (Fig. 1J, arrow). Thus,
in only two overnight hybridizations, the origin of the
small insert could be narrowed down from chromosome
9 (about 138 Mbp) to the long arm of chromosome 9
(about 93 Mbp) to a pair of BAC pools (12.7 Mbp).
Hybridization of individual BAC clones will now allow
to characterize the insert with a resolution of 30-50kb
and identify candidate gene in this region.
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Table 1. Location of BACs, TMP3, and NTRK1 genes on chromosome 1.
a Unique position information is estimated from the Human Genome Reference DNA Sequence, Mapviewer build 36.3 at 
http://www.ncbi.nlm.nih.gov/projects/mapview/.
bThe insert sizes were taken from information available at the NCBI Clone Registry at 
http://www.ncbi.nlm.nih.gov/genome/clone/clname.cgi?stype=Id&list=209311&TransHist=0
Table 2. BAC pool positions, sizes and labelsa 
aProbes labeled with biotin or digoxigenin were detected with avidin-FITC and rhodamine-conjugated antibodies against digoxigenin, respectively 
[CAP: chromosome arm probe].
Discussion
The role of iodine deficiency or ionizing radiation in
the genesis of thyroid tumors and the mechanisms
underlying the progression of benign thyroid disease
(for example, goiters or adenomas) to malignant carci-
nomas are vastly unknown. Specific rearrangements
such as the ret/PTC oncogene or a TMP3-NTRK1
fusion gene product have been suggested as a cause of
malignant transformation of thyroid epithelium, yet
many tumors do not show either abnormality. Thus,
there is an important need to screen PTC specimens for
genetic or chromosomal abnormalities. 
We believe that our BAC-FISH assays, expected to
be an order of magnitude more sensitive that Giemsa
(G)-banding karyotyping, will lead to the identifica-
tion of genes in the breakpoint region(s) and help
define chPTC-candidate genes for expression studies
in normal and tumor tissue. To test this hypothesis, we
have chosen two approaches that identify target
regions of the human genome for subsequent high res-
olution studies using FISH or molecular methods such
as reverse transcription PCR. The first set of experi-
ments resembles a candidate gene approach in which
abnormal chromosomes are identified by G-banding
and/or SKY analysis of metaphase spreads [30], and
BACs that bind at or near candidate genes such as the
before-mentioned TMP3 or NTRK1 are selected from
high complexity libraries. The second approach, which
we applied to the characterization of translocated seg-
ments of chromosome 9 in the chPTC cell line S48TK,
does not make any assumption regarding candidate
genes. Instead, the chromosome under investigation is
divided into increasingly smaller segments, each of
which can be identified by specifically labeled BAC
pools, down to the level of individual clones. Once a
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Fig. 1. FISH-based analysis of chromosomal alterations in a case
of post-Chernobyl childhood thyroid cancer. (A-D) SKY analy-
sis reveals a large number of translocations most of which are
unbalanced (A: pseudo-RGB image, B: chromosome classifica-
tion image, C: inverted DAPI counterstain image, D: SKY kary-
otype table). (E) Dual color FISH analysis of S48TK metaphase
spreads with BACs flanking NTRK1. The insert shows enlarged
images of two copies of a der(1) (left: pseudo-RGB composite
of FISH signals and DAPI counterstain; right: the inverted
DAPI picture). (F) Analysis of S48TK metaphase spreads with
BACs flanking TMP3. The inserts show enlarged images of the
two marker chromosomes, M1 and M2 (left: pseudo-RGB com-
posite of FISH signals and DAPI counterstain; right: the DAPI
picture). (G) Various abnormal chromosomes found in S48TK
metaphase spreads carry material originating from chromosome
9 (shown in white in the classification images). These SKY
images show the pseudo-RGB picture to the left, an inverted
DAPI image in the middle and the corresponding classification
images to the right. The arrow points at a small segment of chro-
mosome 9 material inserted into a der(8)t(8;15) marker chromo-
some. (H) Chromosome arm painting (CAP) probes delineate
the short (red) and long (green) arm of chromosome 9 in normal
metaphase chromosomes. In S48TK metaphase chromosomes,
these probe pools highlight the chromosome 9-derived material
on marker chromosomes. The arrow points to a small segment of
chromosome 9q material on the der(8)t(8;15) marker chromo-
some.(I) Schematic illustrating the use of pooled BAC probes
each covering several megabases on chromosome 9 for mapping
of translocation at the single band resolution. (J) Pools (9-10 +
9-11) specifically bind to the small segment of interest (arrow).
[The images shown in D and G –J are reproduced from Weier et
al. [34] with permission from S. Karger AG, Basel, CH.]
Fig. 2. Schematic diagram of the BAC-FISH pooling strategy for
delineation of chromosomal rearrangements on chromosome 9.
Clones are arranged on 96-well plates such that each row contains
clones which map within a region a few megabasepairs.  Arrows
point from rows on the plate to the target chromosome bands. The
profiles on the right depict copy number changes along chromo-
some 9 in case S48TK, with a region of copy number overrepre-
sentation indicated by a hatched box near the chromosome 9
ideogram. 
BAC clone is identified that binds near a breakpoint or
spans it, a search of publicly available databases such
as the draft sequence of the human genome may rapid-
ly identify candidate genes in this region. However,
caution in the interpretation of such mapping studies is
advised, since cis-acting, regulatory elements may be
tens of kilobases away from their target gene [37].
Historically, breakpoint mapping has been an itera-
tive process based on the definition of the smallest
interval between proximal and distal probes (see arti-
cle by Lu et al. in next issue of Folia Histochemica et
Cytobiologica) [38]. Our work presented here focuses
on using BAC clones rather than yeast artificial chro-
mosomes (YACs), because the BACs have a number
of significant advantages such as a lesser rate of
chimerism [39,40], faster growth or ease of DNA iso-
lation [41]. Another aim of our study was to expedite
the process of mapping translocation breakpoints by
eliminating so-called hybridization failures through
pooling of BAC clones [42,43].
Importantly, our pooling protocol for FISH probe
preparation accelerates the delineation and fine map-
ping of translocation breakpoints without sacrificing
resolution. The turnaround time for each cycle com-
prised of clone selection, FISH and image analysis
using tumor metaphase samples can be as short as 3-4
days. Thus, with translocation breakpoints roughly
determined by G-banding or SKY, large numbers of
BACs can be pulled from in-house libraries, re-
arrayed, grown and assembled in probe pools in a mat-
ter of days. As the chromosome 9-specific example in
this paper shows, only a handful of overnight
hybridizations are required to localize the breakpoint
to a single pool and open the door to high resolution
analysis using single BAC clones. Thus, the proposed
BAC pooling strategy seems capable to provide break-
point information as well as DNA probes suitable for
metaphase or interphase cell analysis in only 2-3
weeks, a significant improvement over previous meth-
ods [44,45].
We believe, our approach reducing the overall costs
of oncogene discovery projects will lead to accelerat-
ed cancer research. The ability to prepare customized,
patient-specific DNA probes can also be of benefit to
patients undergoing anti-cancer therapy by providing
high quality reagents able to detect rare or residual
cancer cells.
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